Info
Dr. Lecia Sequist describes the state of the art and her view of current best practices on molecular testing for advanced non-small cell lung cancer.
8 anni fa
#acquired, #biopsy, #cancergrace, #general, #grace, #gracecast, #hospital, #lecia, #marker, #massachusetts, #molecular, #mutation, #oncology, #rebiopsy, #repeat, #resistance, #sequist, #testing
Scopri di più
Cerca
